Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Allarity To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Allarity between May 17, 2022 and July 19, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi […]
LOS ANGELES, Oct. 16, 2024 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Domino’s Pizza, Inc. (“Domino’s” or “the Company”) (NYSE: DPZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
In the era ofAIGC, intelligent computing power has become a core engine driving the development of the digital economy. On October 16th, at the GITEX Global 2024 in Dubai, H3C launched significant new intelligent computing products, which include the general computing flagship product, H3C UniServer R3900/R4900/R4700/R4300 G7, the diverse heterogeneous computing platforms, H3C UniServer R5300/5500
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Spire To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Spire between May 11, 2022 and August 27, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your iLearningEngines, Inc. (NASDAQ:AILE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ilearningengines-lawsuit-submission-form?prid=108735&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/verve-therapeutics-inc-lawsuit-submission-form?prid=108734&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sage-therapeutics-lawsuit-submission-form?prid=108733&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
BMB-201 demonstrated dose-dependent efficacy in pain models BMB-201 demonstrated similar efficacy to morphine in several pain models NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other CNS disorders, is excited to
PDC, supported by Vance Street Capital, finalized the acquisition of Resenex to provide fluid management solutions focused on supporting the development and production needs of the healthcare and biotechnology sectors. This acquisition enhances PDC’s capabilities to deliver advanced, reliable, and scalable solutions, reinforcing its commitment to providing exceptional customer value and staying at the forefront